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Abstract 
Background: Lipotoxicity is defined as cellular toxicity observed in the presence of an 
abnormal accumulation of fat and adipocyte-derived factors in non-fat tissues. Palmitic acid 
(PA), an abundant fatty acid in the bone marrow and particularly in osteoporotic bones, 
affects osteoblastogenesis and osteoblast function, decreasing their survival through induction 
of apoptosis and dysfunctional autophagy. In this study, we hypothesized that PA also has a 
lipotoxic effect on osteocytes in vitro. 
Methods: Initially, we tested the effect of PA on osteocyte-derived factors DKK1, sclerostin 
and RANKL. Then, we tested whether PA affects survival and causes apoptosis in osteocytes. 
Subsequently, we investigated the effect of PA on autophagy by detecting the membrane 
component LC3-II (Western blot) and staining them and lysosomes with Lysotracker Red 
dye.  
Results: PA decreases RANKL, DKK1 and sclerostin expression in osteocytes. In addition, 
we found that PA induces apoptosis and reduces osteocyte survival. PA also caused 
autophagy failure identified by a significant increase in LC3-II and a reduced number of 
autophagosomes/lysosomes in the cytoplasm.  
Conclusion: In addition to the effects of PA on RANKL, DKK1 and sclerostin expression, 
which could have significant deleterious impact on bone cell coupling and bone turnover, PA 
also induced apoptosis and reduced autophagy in osteocytes. Considering that apoptosis and 
cell dysfunction are two common changes occurring in the osteocytes of osteoporotic bone, 
our findings suggest that PA could play a role in the pathogenesis of the disease. Suppression 
of these effects could bring new potential targets for therapeutic interventions in the future.  
 
Key words: Apoptosis; autophagy; osteocytes; fatty acids; lipotoxicity; palmitic acid. 
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1- Introduction 
Bone quality and quantity decreases with aging due to changes in the structural and material 
properties of bone [1], which is associated with increased skeletal fragility and fractures [2]. 
With aging, there is an increase in progenitor mesenchymal stem cell (MSC) differentiation 
to adipocytes over osteoblasts [3]. Increased expansion of adipocyte component in the bone 
marrow is associated with high levels of fatty acids within the bone marrow milieu, which 
has a variety of effects on bone cells including a toxic effect on osteoblasts, a phenomenon 
termed as lipotoxicity [4]. In bone, lipotoxicity involves the inhibition of osteoblast function 
and survival by adipocyte-secreted factors, predominantly palmitic acid (PA) [5, 6]. In 
addition, adipocyte-secreted factors can reduce hematopoiesis and increase 
osteoclastogenesis by various mechanisms, which can alter bone turnover and lead to bone 
loss[4, 7].  
Osteocytes, which derive from osteoblasts, are the most prevalent bone cells and reside 
within cavities called lacunae [8]. Osteocytes are terminally differentiated from osteoblasts 
and long cell projections from the osteocytes connect to the bone surface through these 
processes that travel through canaliculi. Specific surface markers are expressed on osteocytes 
during the different stages of their differentiation [9]. Osteocytes act as ‘sentinels’ that can 
regulate and modulate bone remodeling and also exhibit endocrine functions through the 
secretion of proteins that regulate bone formation [8]. Like osteoblasts, osteocytes express 
important cell regulatory molecules including membrane-bound receptor activator of nuclear 
factor kappa-Β ligand (RANKL), Dickkopf WNT signalling pathway inhibitor1 (DKK1) and 
sclerostin [8]. High levels of apoptotic osteocytes and many compromised empty lacunae are 
observed in aging and in osteoporotic bone [10, 11], suggesting that these processes are 
associated with changes in the bone microenvironment that affect osteocyte function and 
survival. Loss of osteocytes in bone is associated with acceleration of bone resorption [12, 
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13], with viable osteocytes in the vicinity of apoptotic cells expressing a high RANKL/OPG 
ratio and releasing osteoclastogenic signals [14]. Additionally, with aging, the reduction in 
osteoblast numbers affects osteocyte formation leading to a decrease in osteocyte density and 
mineralization of the osteocyte lacunae [15]. 
Previously, we and others have reported the intrinsic mechanisms of PA-induced lipotoxicity 
in osteoblasts, an effect exerted through induction of dysregulated autophagy and apoptosis in 
human osteoblasts in vitro [5, 6]. Therefore, given that PA-induced autophagy and apoptosis 
are also the most common mechanisms of lipotoxicity in other organs and tissues [16, 17], 
and that autophagy and apoptosis are common features in age-related bone loss and 
osteoporosis [10], we hypothesized that PA could play an important role in the pathogenesis 
of osteocyte apoptosis and dysfunctional autophagy observed in aged and osteoporotic bone.  
 
2- Materials and Methods 
2.1 Osteocytes: MLO-Y4-nGFP murine long bone osteocytes (kindly provided by Dr. Linda 
Bonewald, Indiana University, USA), were plated on 0.01% collagen-coated surfaces (Sigma, 
USA) and grown in α-MEM supplemented with 5% fetal bovine serum (FBS), 5% bovine 
calf serum (BCS), penicillin (100 U/ml) and streptomycin (100 μg/ml). Cells were incubated 
at 37°C under 5% CO2. In order to maintain stable transfection in MLO-Y4-nGFP, 0.4 mg/ml 
G418 antibiotic was added to the media. 
 
2.2 Western blotting: Osteocytes were treated with PA (250 and 500 M), or vehicle alone, 
for 48 h. After various treatment conditions, osteocytes were lysed using lysis buffer (1% 
protease inhibitors) and centrifuged at 13000 g for 10 min to remove insoluble material. 
Before electrophoresis, protein concentrations were measured using the Pierce™ BCA 
Protein Assay Kit (Thermo Fisher Scientific, Scoresby, VIC, Australia) and samples were 
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dissolved in SDS electrophoresis buffer. 10 micrograms of protein per well were separated on 
SDS-polyacrylamide gels and subsequently electro transferred to a PVDF membrane for 50 
min at 300 mA. After blocking with PBS containing 0.1% Tween 20 and 5% BSA, 
membranes were incubated overnight at 4°C using primary antibodies against RANKL, Anti-
Sclerostin primary antibody (Santa Cruz, CA, USA, Cat:sc-130258), and anti- DKK1 (Santa 
Cruz, CA, USA, Cat: sc-374574), or β-tubulin. The bound antibodies were detected with the 
appropriate corresponding secondary antibodies (1:10,000) conjugated with horseradish 
peroxidase. Blots were developed using enhanced chemiluminescence. For measuring 
autophagy, the same procedure was followed except a primary antibody anti-LC3 (Santa 
Cruz, CA, USA) was used instead. Quantification was performed using Image J software. 
Relative intensities of the bands were determined using tubulin as control.  
 
2.3 Confocal microscopy: Cells were grown on collagen-coated coverslips in the absence or 
presence of PA (at each of 250 and 500 M). Cells were then fixed in 4% paraformaldehyde 
for 20 min and washed three times with PBS, permeabilized with 0.1% Triton X-100 in PBS 
for 10 min, washed and blocked with 5% BSA for 1 h. Anti-RANKL antibody (Abcam, 
1:100, ab45039), was added and left overnight at 4°C. Alexa555-conjugated anti-mouse 
antibody (Abcam, 1:1000 ab150110) was used for 45 min at room temperature as the 
secondary antibody. RANKL quantification was performed by calculating the fluorescence 
intensity of RANKL (red channel) using ImageJ software. The red channel was chosen and 
then the image was threshold (converted to black-and-white) such that the red staining was 
represented by white pixels, then the histogram function of the software was used to obtain 
the total count.  The same approach was used for the blue channel to count the number of 
nuclei in the field. Subsequently, the average staining level per cell was calculated. The same 
threshold setting and analysis was performed for all three different experiments using 6-8 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
6 
 
images per condition. 
To determine autophagy, LC3 (Sigma Aldrich, St. Louis, Missouri, USA), was used as the 
primary antibody for identifying autophagosomes. Alexa 488 conjugated donkey anti-rabbit 
(Sigma Aldrich, A-21206, St. Louis, Missouri, USA) was used as the secondary antibody. 
DAPI was added for 3 min, then cells were washed with PBS twice and Golden Pre-Long 
anti-fade (# P36930, Invitrogen) was added before analysis using a Leica SP5 confocal 
microscope. For identification of autophagolysosomes, Lyso-Tracker Red (LTR) dye (Life 
Technologies) (50 nM in media) was used for 30 min and cells were washed with PBS twice 
and antifade was added before analysis using a Leica SP5 confocal microscope.  Control 
samples were incubated with secondary antibody alone. All images are at equal magnification 
and were processed and acquired identically (60x magnification using immersion oil). 
 
2.4 Effect of PA on osteocyte viability: To determine the effect of PA on osteocyte viability, 
osteocytes were plated in 96-well plates at a density of 0.5×10
4
 cells/cm
2
. After an initial 24 h 
period in growth media (time 0), cells were treated with either PA (250 and 500 M) or 
vehicle alone. Cell viability was evaluated at timed intervals (24, 48 h) by MTS assay 
(CellTiter 96® AQueous One Solution Cell Proliferation Assay, Promega, Alexandria, NSW, 
Australia), according to the manufacturer’s instructions. Viability was calculated as the 
percentage change compared with control. This experiment was repeated three times. 
 
2.5 Flow cytometry: Osteocytes were treated with PA (250 and 500 M) and incubated in the 
osteocyte media. After 48 h incubation, apoptotic cells were quantified by Annexin V-PE 
staining. Briefly, osteocytes were harvested by centrifugation, washed with PBS and stained 
for 15 min at room temperature with Annexin V-PE and 7-ADD (BD Biosciences, Cat. No. 
65875X, USA) in Annexin binding buffer, according to the manufacturer's instructions. The 
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samples were then suspended in Annexin binding buffer and the level of fluorescence was 
determined using a BD FACS Verse flow cytometer with Flow Jo software (BD Biosciences, 
USA). Annexin V-PE staining intensity from PA treated and untreated cells were compared 
to show the average fold increase in apoptotic cells. A dual histogram for Annexin V-PE vs 
7-AAD was used to compare the apoptosis from PA-treated and untreated cells.  
Furthermore, to determine whether autophagy is affected by PA in osteocytes, cells were 
incubated with LTR dye (50 nM) for 3 min and the level of fluorescence was measured using 
a BD FACS Verse flow cytometer with Flow Jo software. Briefly, cells were washed in PBS 
buffer and trypsinized with lysis buffer. The cells were then washed with PBS and suspended 
in the presence of DNA viability dye, Propidium Iodide (PI) (Life Technologies, Cat. No. 
BMS500PI, CA, USA). LTR fluorescence intensity values from PA treated and untreated 
cells were compared to show the average fold increase in autophagy. A dual histogram was 
acquired to compare lysosomal fluorescence (representing LTR) with DNA viability dye 
(LTR+/PI+). Flow cytometry acquisition protocols were performed to collect approximately 
10 000 events.  
 
2.6 TUNEL assay: Cells were grown in collagen-coated plates and treated with PA (250 and 
500 M) as previously described. Cells were then trypsinized and fixed with 4% 
paraformaldehyde for 20 min at room temperature and then washed with PBS. TUNEL assay 
(Roche, Basel, Switzerland) for apoptosis was performed according to the manufacturer’s 
instructions. The level of fluorescence was determined using a BD FACS Verse flow 
cytometer with Flow Jo software (BD Biosciences, USA).  
 
2.7 Statistical analysis: All data are expressed as the mean of three replicate determinations, 
unless otherwise stated. Statistical analysis was performed by Student’s t-test. T-tests were 
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performed using a two-tailed distribution with two sample unequal variances. A probability 
value of p < 0.05 was considered statistically significant. 
 
3-Results 
3.1 PA reduces the expression of osteocyte-derived factors: Osteocytes are the most 
important producers of RANKL in bone [18]. Therefore, in this current study we investigated 
whether PA affects RANKL expression in osteocytes. We found a decrease in RANKL 
expression in osteocytes incubated with PA (Figure 1A-C). The number of RANKL-
expressing cells was significantly reduced by the higher dose of PA (Figure 1A and B). 
Western blot quantification showed a significant decrease in RANKL protein expression 
when the cells were incubated with 250 and 500 µM of PA (p<0.05) (Figure 1C and D). In 
addition, there was a significant decrease in DKK1 and sclerostin protein expression when 
cells were incubated with two concentrations of PA (250 and 500 µM) (p<0.05) (Figure 1 E 
and F) 
 
3.2 PA reduces survival and induces apoptosis in osteocytes: Initially, we determined cell 
viability in osteocytes treated with PA for 24 and 48 h (Figure 2A). Treatment with 250 µM 
of PA resulted in 10% reduction of viability at 48 h as compared to control. In addition, 
treatment with 500 µM of PA resulted in 13% and 22% reduction of viability at 24 and 48 h, 
respectively, as compared to control (p<0.01).  
Apoptosis was quantified using two separate techniques: Annexin and TUNEL assays. 
Osteocytes were exposed to two different concentrations of PA (250 and 500 µM) or vehicle 
for 48 h. Figure 2 (B and C) shows Annexin V positive (apoptotic cells) quantified using flow 
cytometry. The total number of apoptotic cells comprises those in early and late apoptosis 
(Figure 2C). While control cells showed 13.8% apoptosis (early 5.6% and late 8.2%), cells 
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cultured with 250 µM PA showed 21.9% apoptosis (early 6.7% and late 15.2%, p<0.01), and 
cells cultured with 500 µM PA showed 25% apoptosis (early 8% and late 17%, p<0.01). 
Quantification for apoptosis using TUNEL at 48 h (Figure 2D and E) found 10% for the 
vehicle-treated cells vs. 24% and 36% for cells incubated with 250 µM and 500 µM PA 
respectively (p<0.01). 
 
3.3 PA decreases lysosome loading and recruitment in osteocytes: Osteocytes were 
incubated in the presence or absence of PA (250 and 500 µM) for 24h and 48h and analyzed 
by flow cytometry for expression of lysosomal loading by using a lysotracker dye. Flow 
cytometry analysis showed that PA caused significantly higher levels of lysosome loading 
compared to control cells (Figure 3 A and B) (p<0.01).  
 
3.4 PA inhibits autophagy in osteocytes: We then investigated whether the increasing levels 
of lysosome loading in the cytoplasm induced by PA treatment were followed by effective 
autophagy. In this case, osteocytes were cultured with three concentrations of PA (100, 250 
and 500 µM). A lower dose of PA was used in these experiments to determine cell sensitivity 
to autophagy under a dose of PA that has not been toxic in previous studies[5, 19]. Initially, 
expression of LC3 protein levels was measured as an indicator of autophagosomes in 
osteocytes. Western blotting quantification showed an increased expression of LC3-II protein 
when exposed to higher concentrations of PA but with no difference between the lower 
concentration of PA and the vehicle-treated controls (Figure 4 A and B). These findings were 
confirmed as indicated by higher levels of LC3-II protein expression (punctate fluorescence 
staining using specific antibody) in the cytoplasm of PA-treated cells (Figure 4C). To 
determine whether formation of autophagosomes and lysosomes recruitment was 
concomitant with efficient formation of autophagolysosomes, cells were incubated in the 
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presence or absence of PA for 48 h with a lysotracker dye LTR and in combination with LC3 
staining. Merged images for PA-treated cells showed lower colocalization of LC3-II and the 
lysotracker probe compared to osteocytes incubated with vehicle (control) (Figure 4C and D).  
 
4- Discussion 
In this study we investigated the lipotoxic effect of PA on osteocytes. Since we have already 
identified apoptosis and dysfunctional autophagy as the two main mechanisms involved in 
PA-induced lipotoxicity in osteoblasts in vitro [6], in this study we investigated whether the 
same mechanisms are involved in osteocyte lipotoxicity. Our results indicate that, as in 
osteoblasts, PA induces apoptosis and inhibits autophagy in osteocytes in vitro, which could 
partially explain the high levels of apoptosis and autophagy observed in osteocytes of aged 
and osteoporotic bone. 
MLO-Y4 cells were utilized in this study as these cells model the properties of osteocytes and 
have proven to be useful for studying apoptosis and cell function related to mature osteocytes 
[12, 20, 21].  The presence of PA in the media affected the capacity of the osteocytes to 
express proteins that are essential for the regulation of bone turnover. Lower levels of 
RANKL could determine a low bone resorption and potential uncoupling. Furthermore, 
considering that DKK1 and sclerostin play crucial roles in bone remodeling, bone formation, 
and bone growth through their effects on osteoblast activity and survival [22, 23], lower 
levels of these proteins induced by the presence of PA could significantly affect bone 
turnover. However, the implications of these findings on bone turnover could only be 
determined by future in vivo studies. 
Apoptosis is an essential mechanism for bone health [24], however, increased osteocyte 
apoptosis could have a deleterious effect on bone as observed in aging mice where osteocyte 
apoptosis was accelerated by loss of sex steroids [25]. In addition, osteocyte apoptosis was 
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observed in high-dose corticosteroid treatment in human biopsies and mice samples [26]. 
Although osteocyte apoptosis could be induced by several factors, such as cytokines, 
hormones, pharmacological agents, and structural changes of bone [27], the mechanisms of 
age-related osteocyte apoptosis remain partially explored thus allowing us to hypothesize that 
this phenomenon could be associated with fatty acid-induced lipotoxicity, which could be the 
consequence of a fatty (and thus lipotoxic) bone marrow milieu. To test whether osteocytes 
are sensitive to toxic fatty acids, we used a similar approach to our previous work using PA, 
which is the most prevalent fatty acid within the human bone marrow milieu [28, 29]. Our 
dosing was calculated as equivalent to the concentrations of PA in the human bone 
marrow[29], with a previously demonstrated lipotoxic effect on osteoblasts in vitro [5, 6, 19].  
Overall, our results indicate that PA induces apoptosis in osteocytes in vitro, which could 
explain their lower rates of survival in the presence of PA in the media.  
PA also induces lipotoxicity on osteoblasts via dysfunctional autophagy [6]. Autophagy is a 
lysosomal degradation process necessary for recycling cellular products. Autophagy is 
generally considered as a survival mechanism, which protects from apoptosis by removing 
damaged organelles, although in extreme stress it leads to cell death [30]. During the 
autophagy process, toxic cytoplasmic contents and damaged organelles trigger lysosomes 
recruitment, which then bind with phagosomes to form single membrane autophagosomes. 
The autophagic process requires many lysosomes to fuse with autophagosomes. It has been 
hypothesized that stimulation of autophagy would be anti-aging whereas a reduction in 
autophagy would promote the aging process[31, 32]. Indeed, healthy levels of autophagy are 
required to maintain an appropriate bone metabolism [33] , however, as observed in age-
related bone loss and osteoporosis, compromised autophagy could significantly affect bone 
turnover and bone mass[11, 34]. 
PA-exposed osteocytes are expected to suffer from cellular stress. In an early stage, their 
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response to PA could consist of lysosomes recruitment while attempting to remove the PA 
from the cytoplasm and protect the cells from lipotoxicity and cell death. If this mechanism 
of cell protection is affected by PA, it may eventually lead to cell death, as we have 
previously observed in human osteoblasts in vitro [6]. In our study, we identified that 
exposure of osteocytes to PA induced significantly higher levels of recruitment of lysosomes 
in the cytoplasm but without an effective formation of autophagolysosomes, thus suggesting 
that the presence of PA affected the autophagy process. These alterations in autophagy 
induced by PA treatment could then explain in part the higher level of apoptosis observed in 
the PA-treated cells. 
In summary, we have found that, as in osteoblasts, PA induces lipotoxicity in osteocytes. 
Exposure of osteocytes to PA decreased their expression of osteocyte-derived factors, which 
are critical to normal bone turnover. In addition, PA induced lipotoxicity through apoptosis 
and inhibition of autophagy clearly mimicking the changes observed in osteocytes of aging 
and osteoporotic bone. However, the significance of these findings could only be determined 
using in vivo models. Most importantly, identification of a potential infiltration of marrow 
toxic fatty acids within the fluid flow through lacunae and canaliculi of bone, thus reaching 
the osteocytes and affecting their function and survival, will be a crucial component of future 
in vivo studies. 
In conclusion, PA induces similar lipotoxic effects on osteoblasts and osteocytes in vitro. 
Although demonstration of this lipotoxic effect in vivo is still lacking, our results allow us to 
suggest that suppression of this lipotoxic effect in vivo could provide the basis to novel 
therapeutic approaches to osteoporosis in the future.  
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Figure legends 
Figure 1. PA reduces the expression of osteocyte-derived factors. (A) Osteocytes MLO-Y4-
nGFP cells were treated with different concentrations of PA (250 and 500 µM) or control. 
Cells were fixed with 4% paraformaldehyde and stained with anti-RANKL. (B) 
Quantification of RANKL+ cells (%) from three different experiments using Image J 
software (*p<0.05 vs control). (C) Osteocytes MLO-Y4-nGFP cells were treated with two 
different concentrations of PA (250 and 500 µM) or control. The figure illustrates the 
detection of RANKL by Western blot. Tubulin was used as a loading control. (D) 
Quantification of three different Western blot experiments using Image J software to analyze 
Western blot bands  (*p<0.05 vs control). (E) Osteocytes MLO-Y4-nGFP cells were treated 
with two different concentrations of PA (250 and 500 µM) or control, and Western blots were 
performed against Sclerostin and DKK1. Tubulin was used as a loading control. (F) 
Quantification of three different experiments using Image J software (*p<0.05 vs control). 
 
Figure 2. PA reduces survival and induces apoptosis in osteocytes. (A) MLO-Y4 osteocytes 
were treated with PA for 24 h and 48 h and MTS assays were performed. Cell survival was 
significantly reduced under PA-treated conditions. Quantification of three different 
experiments (*p<0.05 vs control; p<0.05, 250 µM vs. 500 µM). (B and C) Flow cytometry 
analysis of apoptosis using a two-color (dual color fluorescence) histogram where the 
horizontal axis represents Annexin V-PE and the vertical axis represents 7-AAD. (B) 
Histograms shown are unlabeled cells, control cells, cells treated with 250 µM PA, and cells 
treated with 500 µM PA. (C) PA treatment induced a significantly higher number of Annexin 
V+ cells as compared with vehicle-treated cells (*p<0.01 vs control).  
These results were confirmed by quantification of percentage of apoptotic cells by TUNEL 
assay (D, E) Osteocytes were treated with different concentrations of PA (250 and 500 µM) 
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or vehicle for 48 h. Cells were fixed in 4% paraformaldehyde, permeabilized with Triton X-
100, and a TUNEL assay was performed (D) and percentage of TUNEL positive cells was 
quantified by flow cytometry (E). Data shown are mean ±SD from three separate 
experiments. (*p<0.01 vs. control). 
 
Figure 3. PA treatment decreases lysosome content in osteocytes. (A) Cell were treated with 
PA for 48 hours and analyzed by FACS analysis to measure excitation profiles for lyso-track 
red  (LTR) dye. (B) PA treatment significantly increased lysosome content in osteocytes as 
compared with vehicle-treated cells. Data shown are mean ±SD from three separate 
experiments. (*p<0.01 vs. control). 
 
Figure 4. Effect of PA on autophagy in osteocytes. (A) Osteocytes (MLO-Y4 cells) were 
treated with two different concentrations of PA (250 and 500 µM) or vehicle (control) and 
Western blot was performed against LC3 at 24, 48 and 72 Hrs. Tubulin was used as a loading 
control. (B) Quantification of three different Western blot experiments using Image J 
software. Treatment with PA increased the expression of the autophagy protein LC3II in a 
concentration-dependent manner (*p<0.05 vs control). (C) Images of osteocytes treated with 
two different concentrations of PA (250 and 500 µM) or control. Osteocytes were fixed with 
4% paraformaldehyde and stained with anti-LC3, LTR and DAPI. All images are at equal 
magnification and were processed and acquired identically (60x oil) using a Leica confocal 
microscope and merged images were obtained using Image J software. (D) Quantification of 
three different experiments with LC3 expression using Image J software showing lower 
colocalization of LC3 and LTR indicative of dysfunctional autophagy (*p<0.01 vs control).  
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Highlights 
 Lipotoxicity is defined as cellular toxicity observed in the presence adipocyte-derived 
factors in non-fat tissues. 
 Fatty acids affect osteocyte function and survival 
 Suppression of lipotoxicity could bring new potential targets for therapeutic interventions 
for osteoporosis in the future. 
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